Pietro Orlando

9PUBLICATIONS
6CO-AUTHORS
Rheumatology and arthritisCancer geneticsCharacterisation of biological macromoleculesCarbon capture engineering (excl. sequestration)Pharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Apr 23, 2025
Sustained Efficacy and Low Rate of Adverse Events of Dupilumab in Type-2 CRSwNP Over 48 Months.

Pietro Orlando, Giuseppe Licci, Gennaro Illiano

|Aug 07, 2024
Cystic fibrosis-related chronic rhinosinusitis: the key role of a comprehensive evaluation in the era of highly effective modulator therapy.

Alberto Minzoni, Luca Mazzetti, Pietro Orlando

|May 19, 2024
Efficacy and safety of dupilumab in the treatment of CRSwNP in the real-life setting: a review of the literature.

Marella Reale, Giuseppe Licci, Pietro Orlando

|Nov 01, 2023
Effectiveness of dupilumab versus endoscopic sinus surgery for the treatment of type-2 chronic rhinosinusitis with nasal polyps: a preliminary report.

Pietro Orlando, Giuseppe Licci, Donald Kuitche

Pageof 2